| Subject: | FDA Issues Guidance Document for Implantable Radiofrequency Transponder for Patient Information |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Mon, 27 Dec 2004 - 10:00 am |
| The FDA has issued a guidance document entitled "Class II Special Controls Guidance Document: Implantable Radiofrequency Transponder System for Patient Identification and Health Information". The guidance document speaks to the "VeriChip", which is a radiofrequency tag about the size of a grain of rice, and is inserted under the skin in the arm of a patient with a needle. The insertion procedure length is approximately twenty minutes. Once the device has been implanted in a patient's skin, the... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
External Links:
|
|
StayAlert!® Virtual Compliance Administrator™ keeps clients informed by email of any changes to Federal regulations, including Joint Commission (TJC, formerly JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG, and many more, and also provides downloadable tools to ensure compliance. StayAlert! is a premium product sold as an annual site-license subscription. With the site license, the client can sign up an unlimited number of users for the email alerts and access to the StayAlert! online regulatory library. The StayAlert! system was designed by healthcare professionals actively working in the healthcare environment, who were faced with attempting to competently provide quality care and services while "doing more with less". StayAlert! provides the answer to efficiently performing a variety of required job components from one centralized virtual location. StayAlert! improves data sharing and communications, thus reducing cost, broadening access and providing a system of documentation and follow-up. |
|
